Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan A Herold

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Physical Chemistry Letters|June 25, 2021
Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated VariantRyan A Herold, Raphael Reinbold, Clare F Megarity, et al.
Journal of the American Chemical Society|October 27, 2025
<i>De Novo</i> Design of a Metalloprotein with a Synthetically Inspired Dinuclear Paddlewheel Coordination MotifAlexander M Hoffnagle, Ryan A Herold, Chia-Ying Tsai, et al.
The Journal of Biological Chemistry|January 9, 2023
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2Xiao Liu, Raphael Reinbold, Shuang Liu, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Physical Chemistry Letters|June 25, 2021
Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated VariantRyan A Herold, Raphael Reinbold, Clare F Megarity, et al.
Journal of the American Chemical Society|October 27, 2025
<i>De Novo</i> Design of a Metalloprotein with a Synthetically Inspired Dinuclear Paddlewheel Coordination MotifAlexander M Hoffnagle, Ryan A Herold, Chia-Ying Tsai, et al.
The Journal of Biological Chemistry|January 9, 2023
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2Xiao Liu, Raphael Reinbold, Shuang Liu, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 2